Watch as Matt, an XCOPRI® (cenobamate tablets) CV patient with partial-onset seizures,
together with his wife, share what led to Matt’s decision to participate in the XCOPRI clinical
study. By talking about Matt’s epilepsy treatment journey, they hope to inspire others to join
the fight for what may be possible with XCOPRI.
Matt is a real patient, and his results may not be representative of all patients. Individual results may vary. Talk with your healthcare provider about any questions you may have regarding your treatment regimen.
IMPORTANT SAFETY INFORMATION FOR XCOPRI® (cenobamate tablets) CV
DO NOT TAKE XCOPRI® IF YOU:
• Are allergic to cenobamate or any of the other ingredients in XCOPRI.
• Have a genetic problem (called Familial Short QT syndrome) that affects the electrical system of the heart.
XCOPRI® CAN CAUSE SERIOUS SIDE EFFECTS, INCLUDING:
Allergic reactions: XCOPRI can cause serious skin rash or other serious allergic reactions which may affect organs and other parts of your body like the liver or blood cells. You may or may not have a rash with these types of reactions. Call your healthcare provider right away and go to the nearest emergency room if you have any of the following: swelling of your face, eyes, lips, or tongue, trouble swallowing or breathing, a skin rash, hives, fever, swollen glands, or sore throat that does not go away or comes and goes, painful sores in the mouth or around your eyes, yellowing of your skin or eyes, unusual bruising or bleeding, severe fatigue or weakness, severe muscle pain, frequent infections, or infections that do not go away. Take XCOPRI exactly as your healthcare provider tells you to take it. It is very important to increase your dose of XCOPRI slowly, as instructed by your healthcare provider.
Please see full Important Safety Information starting at 2:54 of the video and full Prescribing Information and Medication Guide at XCOPRI.com.
Ready to join the fight? Learn more at www.XCOPRI.com
Негізгі бет Matt’s Epilepsy Treatment Journey to Zero Seizures
Пікірлер